XELODA 150 (Xeloda 150 mg)
Generic Name: capecitabine
Pill imprint XELODA 150 has been identified as Xeloda 150 mg.
Xeloda is used in the treatment of colorectal cancer; breast cancer, metastatic; pancreatic cancer; breast cancer; stomach cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Xeloda 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for XELODA 150 (Xeloda 150 mg)
- Generic Name:
- 150 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Roche Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
hypromellose 2208 (15000 mPa.s)
ferric oxide red
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54868-4143||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Xeloda (capecitabine)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...